Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Guim, Kwon"'
Publikováno v:
Antioxidants, Vol 13, Iss 9, p 1034 (2024)
Recent advances in cardiovascular research have increasingly emphasized oxidative stress as a central mechanism in the pathogenesis and progression of cardiovascular diseases [...]
Externí odkaz:
https://doaj.org/article/d8324ab90f5942048b29d62314a1349f
Autor:
Omer Batuhan Kirilmaz, Akshay Radhakrishna Salegaonkar, Justin Shiau, Guney Uzun, Hoo Sang Ko, H Felix Lee, Sarah Park, Guim Kwon
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254718 (2021)
Artificial pancreas system (APS) is an emerging new treatment for type 1 diabetes mellitus. The aim of this study was to develop a rat APS as a research tool and demonstrate its application. We established a rat APS using Medtronic Minimed Pump 722,
Externí odkaz:
https://doaj.org/article/880be15e0faa4a5ca5fc7de52048a1c7
Autor:
Sakineh Esmaeili Mohsen Abadi, Ramin Balouchzadeh, Guney Uzun, Hoo Sang Ko, H. Felix Lee, Sarah Park, Guim Kwon
Publikováno v:
Heliyon, Vol 6, Iss 1, Pp e03251- (2020)
Obesity is one of the primary causes of type 2 diabetes mellitus (T2DM). To better understand how obesity impairs glucose-insulin homeostasis, we tracked fasting blood glucose and insulin levels and the key components of glucose-insulin homeostasis f
Externí odkaz:
https://doaj.org/article/afc36f14903d41648288a30b94d881a6
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cardiovascular Pharmacology.
Autor:
Michael Brenner, Sakineh Esmaeili Mohsen Abadi, Ramin Balouchzadeh, H. Felix Lee, Hoo Sang Ko, Michael Johns, Nehal Malik, Joshua J. Lee, Guim Kwon
Publikováno v:
Heliyon, Vol 3, Iss 6, Pp e00310- (2017)
Destruction of the insulin-producing β-cells is the key determinant of diabetes mellitus regardless of their types. Due to their anatomical location within the islets of Langerhans scattered throughout the pancreas, it is difficult to monitor β-cel
Externí odkaz:
https://doaj.org/article/e916ff68a0414c6cace168305eef11cf
Autor:
Guim Kwon, Omer Batuhan Kirilmaz, Justin Shiau, Sarah Park, Akshay Radhakrishna Salegaonkar, Guney Uzun, H. Felix Lee, Hoo Sang Ko
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254718 (2021)
PLoS ONE
PLoS ONE
Artificial pancreas system (APS) is an emerging new treatment for type 1 diabetes mellitus. The aim of this study was to develop a rat APS as a research tool and demonstrate its application. We established a rat APS using Medtronic Minimed Pump 722,
Publikováno v:
Procedia Manufacturing. 39:341-348
Advances in sensing and communication technologies have enabled a tight integration between computational and physical elements that is known as cyber-physical systems (CPS). This integration has been also applied to medical devices and healthcare sy
Autor:
Guim Kwon, H. Felix Lee, Sarah Park, Ramin Balouchzadeh, Sakineh Esmaeili Mohsen Abadi, Guney Uzun, Hoo Sang Ko
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 1, Pp e03251-(2020)
Heliyon, Vol 6, Iss 1, Pp e03251-(2020)
Obesity is one of the primary causes of type 2 diabetes mellitus (T2DM). To better understand how obesity impairs glucose-insulin homeostasis, we tracked fasting blood glucose and insulin levels and the key components of glucose-insulin homeostasis f
Autor:
Tracy, Knobeloch, Sakineh Esmaeili Mohsen, Abadi, Joseph, Bruns, Silviya Petrova, Zustiak, Guim, Kwon
Publikováno v:
Biomedical physicsengineering express. 3
An injection of hydrogel-encapsulated islets that controls blood glucose levels over long term would provide a much needed alternative treatment for type 1 diabetes mellitus (T1DM). To this end, we tested the feasibility of using an injectable polyet
Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system
Publikováno v:
Medicalbiological engineeringcomputing. 57(1)
Artificial pancreas system (APS) is a viable option to treat diabetic patients. Researchers, however, have not conclusively determined the best control method for APS. Due to intra-/inter-variability of insulin absorption and action, an individualize